Downloads: 163

Files in This Item:
File Description SizeFormat 
sciadv.1400203.pdf2.15 MBAdobe PDFView/Open
Title: Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia
Authors: Tada, K.
Kobayashi, M.
Takiuchi, Y.
Iwai, F.
Sakamoto, T.
Nagata, K.
Shinohara, M.
Io, K.
Shirakawa, K.
Hishizawa, M.
Shindo, K.
Kadowaki, N.
Hirota, K.
Yamamoto, J.
Iwai, S.
Sasanuma, H.
Takeda, S.
Takaori-Kondo, A.
Author's alias: 多田, 浩平
小林, 正行
瀧内, 曜子
武田, 俊一
高折, 晃史
Issue Date: 24-Apr-2015
Publisher: American Association for the Advancement of Science
Journal title: Science Advances
Volume: 1
Issue: 3
Thesis number: e1400203
Abstract: Adult T cell leukemia (ATL) is an aggressive T cell malignancy caused by human T cell leukemia virus type 1 (HTLV-1) and has a poor prognosis. We analyzed the cytotoxic effects of various nucleoside analog reverse transcriptase inhibitors (NRTIs) for HIV-1 on ATL cells and found that abacavir potently and selectively kills ATL cells. Although NRTIs have minimal genotoxicities on host cells, the therapeutic concentration of abacavir induced numerous DNA double-strand breaks (DSBs) in the chromosomal DNA of ATL cells. DSBs persisted over time in ATL cells but not in other cell lines, suggesting impaired DNA repair. We found that the reduced expression of tyrosyl-DNA phosphodiesterase 1 (TDP1), a repair enzyme, is attributable to the cytotoxic effect of abacavir on ATL cells. We also showed that TDP1 removes abacavir from DNA ends in vitro. These results suggest a model in which ATL cells with reduced TDP1 expression are unable to excise abacavir incorporated into genomic DNA, leading to irreparable DSBs. On the basis of the above mechanism, we propose abacavir as a promising chemotherapeutic agent for ATL.
Description: 抗HIV-1薬の新規抗癌作用の解明に成功 -難治性血液がんである成人T細胞白血病の新規治療に期待-. 京都大学プレスリリース. 2015-04-27.
Rights: © 2015, The Authors This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
DOI(Published Version): 10.1126/sciadv.1400203
Related Link:
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.